Avet Pharmaceuticals Inc. Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Avet Pharmaceuticals Inc. Pharmaceutical Import Records from India — 6 Products, $17.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Avet Pharmaceuticals Inc. — Pharmaceutical Importer Profile (2026) | 6 Products, $17.6M Trade | TransData Nexus

Avet Pharmaceuticals Inc.

Pharmaceutical Importer · United States · Gastrointestinal Focus · $17.6M Total Trade · DGFT Verified

Avet Pharmaceuticals Inc. is a pharmaceutical importer based in United States with a total trade value of $17.6M across 6 products in 5 therapeutic categories. Based on 358 verified import shipments from Indian Customs (DGFT) records, Avet Pharmaceuticals Inc. is the #1 buyer in 1 product including Metoclopramide. Avet Pharmaceuticals Inc. sources from 8 verified Indian suppliers, with Avet Lifesciences Private Limited accounting for 62.5% of imports.

Avet Pharmaceuticals Inc. — Import Portfolio & Supplier Network

Avet Pharmaceuticals Inc. import network — 6 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Avet Pharmaceuticals Inc.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Avet Lifesciences Private Limited	$16.3M	391	62.5%
Emcure Pharmaceuticals Limited	$3.1M	119	11.9%
Usv Private Limited

What Formulations Does Avet Pharmaceuticals Inc. Import?

Formulation	Value	Ships
Ondansetron injection USP 2MG/ML, 2ML	$716.7K	15
Fluoxetine capsules USP , 20 MG (Pack	$478.7K	43
Ondansetron injection USP 2MG/ML,2ML vial(25#s Pack )	$406.2K	9
(medicines)-adenosine INJ 3 MG/ML (20 ML	$383.6K	8
Midazolam injection 2MG/2ML (1MG/ML	$346.5K	9
Modafinil tablets USP , 200 MG (Pack	$322.6K	9
(medicines) prochlorperazi edi INJ us 10x2ml avet sn details as per	$300.0K	6
(medicines)-acetazolamide for INJ	$294.1K	6
Doxycycline tablets 100MG, 500's us	$250.0K	5
Medicines:propofol INJ 200MG/20mlx20 avet sn anda no. 206408 batch no. es230281a mfg dt:nov/2023 exp. date	$232.7K	6
Medicines:propofol INJ 200MG/20mlx20 avet sn anda no. 206408 batch no. es230302amfg. date :dec/2023 exp.	$232.4K	6
Medicines-propofolinj emul1%(200MG/20ML)x10avet sn batch no:es240093a mfg date:apr/2024 exp date	$231.7K	6
Medicines:propofol INJ 200MG/20mlx20 avet sn anda no. 206408 batch no. es230299amfg. date : dec/2023 exp.	$230.0K	6
Medicines:propofol INJ 200MG/20mlx20 avet sn anda no. 206408 batch no. es230283amfg. date : dec/2023 exp.	$229.6K	6
Medicines:amikacin sulfat INJ us 500MG/2ML avet sn anda no. 204040 batch no. es230305a mfg dt:dec/2023 exp	$201.9K	6

Avet Pharmaceuticals Inc. imports 381 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 6 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Doxycycline	Antibiotics	$6.3M	126	5.3%	2
2	Ondansetron	Gastrointestinal	$5.5M	111	4.6%	3
3	Amikacin	Advanced Antibiotics	$2.6M	52	8.3%	2
4	Metoclopramide	Gastrointestinal	$1.6M	32	4.0%	1
5	Furosemide	Diuretics	$1.5M	35	2.1%	9
6	Carmustine	Advanced Oncology	$100.0K	2	0.4%	4

Avet Pharmaceuticals Inc. imports 6 pharmaceutical products across 5 categories into United States totaling $17.6M. The company is the #1 buyer for 1 product: Metoclopramide.

Avet Pharmaceuticals Inc. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Avet Pharmaceuticals Inc. is a rapidly growing generic pharmaceutical company headquartered in East Brunswick Township, New Jersey. Established in 2004, the company specializes in the acquisition, licensing, development, marketing, sale, and distribution of generic pharmaceutical products for the global prescription drug market. Avet Pharmaceuticals offers a diverse portfolio across various therapeutic categories, including cardiovascular, oncology, metabolic diseases, anti-infectives, and pain management. The company focuses on both widely utilized generics and niche products with limited competition and long life cycles.

Avet Pharmaceuticals operates with a virtual business model, outsourcing manufacturing and development to FDA-approved partners in North America, Europe, and Asia. This approach enhances cost efficiency and ensures regulatory compliance. The company's mission is to provide affordable, accessible, and quality medicines that improve patient health outcomes. Avet's vision emphasizes delivering exceptional generic drugs and fostering strong customer relationships.

2Distribution Network

Avet Pharmaceuticals' distribution network is strategically designed to ensure efficient delivery of its products across the United States. The company maintains a primary office at One Tower Center Blvd, Suite 1700, East Brunswick Township, New Jersey 08816. While specific warehouse locations are not publicly disclosed, Avet's global supply chain network includes manufacturing and packaging capabilities in the U.S., as well as partnerships with FDA-approved facilities in North America, Europe, and Asia. This extensive network enables Avet to provide high-quality generic medicines to a broad customer base, ensuring timely and reliable distribution.

3Industry Role

Avet Pharmaceuticals Inc. plays a significant role in the United States pharmaceutical supply chain as a generic pharmaceutical company. By focusing on the acquisition, development, and distribution of generic drugs, Avet contributes to enhancing the affordability and accessibility of medications for patients and healthcare providers. The company's emphasis on both widely used generics and niche products with limited competition positions it as a key player in providing cost-effective healthcare solutions.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Avet Pharmaceuticals Inc.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Avet Pharmaceuticals Inc. demonstrates a high level of sourcing concentration, with a significant portion of its imports originating from a single supplier, AVET LIFESCIENCES PRIVATE LIMITED. This supplier accounted for $16.3 million in imports, representing 62.5% of the total import value. The company's top five products—Doxycycline, Ondansetron, Amikacin, Metoclopramide, and Furosemide—comprise 99.4% of its total imports, indicating a focused product portfolio. This concentration suggests a strategic choice to streamline operations and maintain strong supplier relationships. However, such dependency also introduces potential risks, including supply chain disruptions and pricing volatility. The stability of these relationships is crucial for Avet's operational continuity and market competitiveness.

2Supply Chain Resilience

Avet Pharmaceuticals Inc.'s supply chain resilience is closely tied to its sourcing strategy. The company's reliance on a limited number of suppliers, particularly AVET LIFESCIENCES PRIVATE LIMITED, may pose challenges in terms of supply chain flexibility and risk management. The diversity of formulations imported—381 unique formulations—indicates a broad product range, which can mitigate some risks associated with product-specific supply chain disruptions. However, the heavy reliance on a single supplier for a substantial portion of imports necessitates robust contingency planning and the development of alternative supplier relationships to enhance supply chain resilience.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth requirements for the safety, efficacy, and quality of drugs imported into the U.S. Pharmaceutical imports must comply with FDA regulations, including establishment registration, drug listing, and labeling requirements. The FDA reviews imported drugs to ensure they meet these standards and may refuse entry to products that are adulterated, misbranded, or unapproved.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States include the registration of foreign drug establishments with the FDA and the listing of all drug products intended for import. Manufacturers must comply with Good Manufacturing Practices (GMP) to ensure product quality and safety. The FDA recognizes GMP certifications from various international standards, including EU GMP, WHO GMP, and PIC/S, provided they meet FDA criteria. Wholesale distributors must obtain authorization from the FDA to operate legally within the U.S. market.

Quality & Labeling

Avet Pharmaceuticals Inc. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Avet Pharmaceuticals Inc.'s product strategy focuses on a diverse range of therapeutic categories, including cardiovascular diseases, oncology, metabolic diseases, anti-infectives, and pain management. The company's portfolio encompasses both widely utilized generics and niche products with limited competition and long life cycles. This strategic approach allows Avet to address a broad spectrum of patient needs while maintaining a competitive edge in the market. The emphasis on high-quality generic medicines aligns with the company's mission to provide affordable and accessible healthcare solutions.

2Sourcing Profile

Avet Pharmaceuticals Inc. employs a sourcing strategy that leverages a global network of manufacturing and scientific excellence. The company outsources manufacturing and development to FDA-approved partners in North America, Europe, and Asia, enhancing cost efficiency and regulatory compliance. This approach allows Avet to offer a wide range of generic pharmaceutical products across various therapeutic categories. The company's focus on both widely utilized generics and niche products with limited competition reflects a strategic balance between market demand and operational capabilities.

3Market Positioning

Seller's Guide — How to Become a Supplier to Avet Pharmaceuticals Inc.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Avet Pharmaceuticals Inc. to supply generic pharmaceutical products. Avet's sourcing strategy, which includes outsourcing manufacturing and development to FDA-approved partners in North America, Europe, and Asia, indicates a willingness to collaborate with international suppliers. Indian exporters can explore this opportunity by offering competitive pricing, reliable supply, and high-quality products that meet FDA standards. Establishing a partnership with Avet could provide access to the U.S. market and contribute to the company's strategic goals of expanding its product portfolio and market presence.

2Requirements & Qualifications

Indian exporters seeking to supply Avet Pharmaceuticals Inc. and the U.S. market must ensure compliance with FDA regulations,

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Avet Pharmaceuticals Inc.

What products does Avet Pharmaceuticals Inc. import from India?

Avet Pharmaceuticals Inc. imports 6 pharmaceutical products across 5 categories. Top imports: Doxycycline ($6.3M), Ondansetron ($5.5M), Amikacin ($2.6M), Metoclopramide ($1.6M), Furosemide ($1.5M).

Who supplies pharmaceuticals to Avet Pharmaceuticals Inc. from India?

Avet Pharmaceuticals Inc. sources from 8 verified Indian suppliers. The primary supplier is Avet Lifesciences Private Limited (62.5% of imports, $16.3M).

What is Avet Pharmaceuticals Inc.'s total pharmaceutical import value?

Avet Pharmaceuticals Inc.'s total pharmaceutical import value from India is $17.6M, based on 358 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Avet Pharmaceuticals Inc. focus on?

Avet Pharmaceuticals Inc. imports across 5 categories. The largest: Gastrointestinal (40.6%), Antibiotics (35.8%), Advanced Antibiotics (14.8%).

Get Full Avet Pharmaceuticals Inc. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.